Nikko Asset Management Americas’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.2M Sell
2,940,793
-304,713
-9% -$1.16M 0.14% 84
2025
Q4
$11.2M Sell
3,245,506
-384,418
-11% -$1.71M 0.13% 87
2025
Q3
$20M Buy
3,629,924
+2,040,807
+128% +$8.29M 0.19% 81
2025
Q2
$3.89M Sell
1,589,117
-1,336,906
-46% -$2.06M 0.04% 110
2025
Q1
$5.82M Sell
2,926,023
-164,157
-5% -$419K 0.08% 95
2024
Q4
$9.02M Sell
3,090,180
-92,275
-3% -$324K 0.1% 87
2024
Q3
$12.3M Sell
3,182,455
-55,930
-2% -$259K 0.14% 83
2024
Q2
$16.5M Sell
3,238,385
-126,278
-4% -$766K 0.19% 72
2024
Q1
$23.5M Sell
3,364,663
-154,366
-4% -$1.17M 0.23% 65
2023
Q4
$31.2M Sell
3,519,029
-115,819
-3% -$892K 0.3% 58
2023
Q3
$34.6M Buy
3,634,848
+570,232
+19% +$7.41M 0.41% 52
2023
Q2
$44.8M Buy
3,064,616
+2,065,283
+207% +$28.8M 0.47% 44
2023
Q1
$11M Buy
999,333
+511,107
+105% +$8.33M 0.13% 78
2022
Q4
$9.04M Buy
+488,226
New +$8.82M 0.13% 88

Other funds holding PRME